М Тухтаева
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
М Тухтаева has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Markhabo Rakhmatova
Bukhara State Medical Institute named after Abu Ali Ibn Sino
1 shared publication - Nigora Ashurova
Bukhara State Medical Institute, Uzbekistan, Bukhara
1 shared publication
Latest Publications
- 1 January 2026
- Published by Bukhara State Medical Institute named after Abu Ali ibn Sino in Scientific and Innovative Therapy
- Vol. 5 (2) , 1531-1543
THE IMPACT OF MICROPLASTIC PARTICLES ON THE FUNCTIONAL STATE OF ALVEOLAR MACROPHAGES
Microplastic particles (MP) have emerged as a critical concern in environmental medicine. This review analyzes the literature published from 2021 to 2026 on the mechanisms by which MPs enter the human body via the respiratory tract, accumulate in lung tissue, impair pulmonary macrophage immunological functions, and trigger inflammatory and oxidative stress pathways. Evidence indicates that inhaled MPs reduce macrophage phagocytic capacity, disrupt lysosomal processing, activate the NLRP3 inflammasome, and trigger reactive oxygen species overproduction. These changes may predispose individuals to chronic pulmonary diseases, fibrosis, and lung cancer.
- 1 January 2026
- Published by Bukhara State Medical Institute named after Abu Ali ibn Sino in Scientific and Innovative Therapy
- Vol. 5 (2) , 1531-1543
THE IMPACT OF MICROPLASTIC PARTICLES ON THE FUNCTIONAL STATE OF ALVEOLAR MACROPHAGES
Microplastic particles (MP) have emerged as a critical concern in environmental medicine. This review analyzes the literature published from 2021 to 2026 on the mechanisms by which MPs enter the human body via the respiratory tract, accumulate in lung tissue, impair pulmonary macrophage immunological functions, and trigger inflammatory and oxidative stress pathways. Evidence indicates that inhaled MPs reduce macrophage phagocytic capacity, disrupt lysosomal processing, activate the NLRP3 inflammasome, and trigger reactive oxygen species overproduction. These changes may predispose individuals to chronic pulmonary diseases, fibrosis, and lung cancer.